Trastuzumab derived HER2-specific CAR for trastuzumab-resistant breast cancer: CAR T-cells successfully engage target epitopes that are not accessible to antibodies

Szoor, A. and Toth, G. and Zsebik, B. and Szabo, V. and Eshhar, Z. and Abken, H. and Vereb, G. (2019) Trastuzumab derived HER2-specific CAR for trastuzumab-resistant breast cancer: CAR T-cells successfully engage target epitopes that are not accessible to antibodies. HUMAN GENE THERAPY, 30 (11). A7-A7. ISSN 1043-0342, 1557-7422

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Regensburger Centrum für Interventionelle Immunologie (RCI)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 23 Mar 2020 11:47
Last Modified: 23 Mar 2020 11:47
URI: https://pred.uni-regensburg.de/id/eprint/25906

Actions (login required)

View Item View Item